Professor in Diabetes and Nephrology, #Exeterdiabetes views my own https://xitter.cf/t.co/ocpC8DJt2M
Exeter, UK
Joined July 2009
- Tweets1.9K
- Following1.5K
- Followers1.3K
- Likes5.8K
Richard Oram retweeted
If there was one article you want to read as a clinician?
Read this
Via @jenna_taglienti - an absolutely stunning write in @JAMA_current
"Medicine can have extraordinary meaning. But it cannot substitute for being present in your own life. The world may need us as physicians.
But the people who love us need us as ourselves.
And that is the role no one else can fill."
Brilliant - and much love to you
'Time is Finite"
jamanetwork.com/journals/jam…
Richard Oram retweeted
Continuous glucose monitoring in early-stage #Type1Diabetes for screening, staging & monitoring: what’s promising, what’s missing, and what’s needed for regulatory qualification #CGM link.springer.com/article/10… 🔓 @alicelouisejane @BesserBesser
Richard Oram retweeted
In 5065 multi-ethnic mother–infant pairs, fetal genetic risks for insulin resistance secondary to lipodystrophy and impaired fasting glucose (IFG) led to reduced fetal growth, while maternal genetic risks for IFG and obesity led to increased growth link.springer.com/article/10… 🔓
Richard Oram retweeted
Up front & free to read in our Feb issue #editorspicks: Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection doi.org/10.1007/s00125-025-0…
Out today in @TheLancetEndo 10% of the UK adults with the highest T1D GRS have an 8x increased risk of pre-clinical, stage 1 T1D, as defined by 2 autoantibodies.
@UniofExeter #ExeterDiabetes @ExeterMed @BT1DUK @DiabetesUK
thelancet.com/journals/landi…
Richard Oram retweeted
To prescribe or not to prescribe? #SGLT2 inhibitors slow #CKD progression but it's unclear who with #T2D and mild/no CKD truly benefits. This new model predicts individual benefit, supporting more targeted prescribing. #PrecisionMedicine link.springer.com/article/10… 🔓@Exeter_Diabetes
Richard Oram retweeted
Please review and consider supporting this important initiative for UK diabetes care
@elsadiabetes @Diabetescouk @DiabetesUK @BreakthroughT1D @unibham_SoBMS
41000 signatures so far! Amazing and thank you all. BUT, time is running out. We’ve only got until 20th December to get to 100000 to get this systemic issue debated in parliament. Please everyone. Type 1 diabetes is a serious condition, if not detected at a GP appointment, kills. It is not type 2 diabetes it is an autoimmune condition! It is rising, it does not care who you are, it does not care if it’s hereditary or not, it does not care if you’re healthy or unhealthy, it does not care about your ethnicity and it does not care about your age. I beg everyone on Facebook with uk citizenship, sign this petition. It is for testing where symptoms warrant it. Do it for you, do it for your mate, do it for your kids, do it for your grandkids, but most of all, do it for our beautiful little girl and everyone that has been badly treated around diagnosis of Type 1 Diabetes x #LylasLaw 💛💝🌻
petition.parliament.uk/petit…
Richard Oram retweeted
Delighted to be at Parliament today launching our white Paper on T1D Early Detection at the All Party Parliamentary Group (APPG) for Diabetes
Richard Oram retweeted
Big announcement: I’m starting a lab at @cityofhope in the Department of Diabetes Immunology this October! Huge thanks to @ufdiabetes @Bruskolab for the mentorship and support without which I could not have achieved this dream of mine. Recruiting lab members
soon!
Richard Oram retweeted
Can the onset of Type 1 diabetes be delayed ? Listen to Hannah and Nick Thomas talk about the possibilities and treatment 1in6b.com/series-4-episode-3…
Excited to share this fantastic @T1D_TrialNet paper by @erinltempleman @EmKSims Lauric Ferrat, Nick Thomas @cevansmo @catespeake and colleagues @UniofExeter @ExeterMed #ExeterDiabetes @IUSweetTweets
diabetesjournals.org/care/ar…
Richard Oram retweeted
Thrilled to share this freshly minted research publication from our @Exeter_Diabetes Global Health Research Group.
Not all young people with #diabetes in #Africa have #T1D. A novel subtype is present.
👍🏾 to all the co-authors and
@NIHRresearch for the core funding.
New—Non-autoimmune, insulin-deficient #diabetes in children and young adults in #Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study thelancet.com/journals/landi… #T1D
#OpenAccess
Richard Oram retweeted
As always, such a pleasure to work with Erin Templeman from the @UniofExeter team, @RAOram, and Lauric Ferrat, as well as an excellent team of collaborators like @cevansmo @catespeake and others who are not on this platform. @IUSweetTweets
Richard Oram retweeted
Super excited this paper on islet autoantibody positive adults is finally online- we analyzed screening and #T1D progression in 100K adult relatives screened as part of @T1D_TrialNet . Available at: bit.ly/4md4scn
Richard Oram retweeted
🚨 Big news! Excited to share my first PhD paper! 🎉
We validated & improved a T1D risk model using TrialNet data (originally from TEDDY), boosting accuracy 📈
bmcmedicine.biomedcentral.co…
Try the web tool 👉 t1dpredictor.diabetesgenes.o…
#T1D #RiskPrediction #PrecisionMedicine
Richard Oram retweeted
💻 The code is open source and available with documentation and examples to support reproducible GRS calculation from summary statistics: github.com/stevensquires/sim…
Richard Oram retweeted
🧬 Find it in Bioinformatics Advances: "Calculating genetic risk scores directly from summary statistics with an application to type 1 diabetes"
Read the full paper here: doi.org/10.1093/bioadv/vbaf1…
Authors include: @RAOram
Richard Oram retweeted
Linked Comment by Jannet Svensson:
Non-autoimmune, insulin-deficient #diabetes in sub-Saharan #Africa thelancet.com/journals/landi… #T1D
#FREE to read with registration (also FREE)
Richard Oram retweeted
New—Non-autoimmune, insulin-deficient #diabetes in children and young adults in #Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study thelancet.com/journals/landi… #T1D
#OpenAccess